MOUNTAIN VIEW, Calif., June 3 /PRNewswire/ -- Concentric Medical, Inc., the global leader in acute ischemic stroke intervention, announced completion of enrollment in the Merci Registry with a total of 1,000 patients enrolled. The Merci Registry is a real-world, international, post-market study of the Merci Retrieval System®. Since its launch in June 2007, over 30 sites worldwide have contributed patients to the Registry, which is the largest repository of prospectively collected multi-center data on mechanical embolectomy in acute ischemic stroke patients. The principal investigators for the Registry are Marilyn Rymer, MD, Founder and Director of the Stroke Center at Saint Luke's Hospital in Kansas City, Missouri, and Wade Smith, MD, PhD, Professor of Neurology at the University of California at San Francisco.
Since its inception, the Registry has captured a wide variety of data, including acute procedural data, patient care protocols, and longer term outcomes that have played a critical role in Concentric Medical's ability to continually improve the technical success and ease of use of the Merci Retrieval System. Participating physicians and Concentric Medical are analyzing patient care protocols and longer term outcomes to further the stroke community's understanding of best practices for the acute care and management of stroke victims. Previous interim analyses of these data were presented at major stroke conferences including the Society for NeuroInterventional Surgery and the International Stroke Conference and have garnered widespread attention.
Upon enrollment of the 1,000th patient in the Registry, Dr. Rymer commented, "The Merci Registry has already proven to be an important benchmarking tool that has provided physicians who treat stroke with important information on the benefits offered by mechanical intervention, as well as insight into how best to care for patients who suffer from this devastating disease. This data will be a rich source of knowledge that will continue to be explored for years to come and because we are still in the early phases of treatment of acute ischemic stroke, it will also serve as a platform for generating new hypotheses and may ultimately help shape the future of research and patient care."
Regarding the Merci Registry's impact on acute ischemic stroke intervention, Maria Sainz, President and CEO of Concentric Medical, said, "The completion of the Registry, the first of its kind in stroke intervention with 1,000 patients enrolled in less than three years, is a significant accomplishment. The learnings from the Registry are deep, as demonstrated by the eight papers presented during ISC 2010. We look forward to facilitating the analyses of the data with the stroke clinicians to advance the field of stroke intervention."
About Concentric Medical
Concentric Medical is located in Mountain View, California and is the global leader in the development of endovascular devices for revascularizing stroke patients. The company manufactures and markets solutions for ischemic stroke: minimally invasive devices that are delivered into the brain to restore blood flow by removing blood clots that cause ischemic stroke. Concentric Medical's devices are available in over 500 leading stroke centers around the world, and have been the subject of several clinical studies. For more information about Concentric Medical, please visit www.concentric-medical.com.
About Acute Ischemic Stroke
Stroke is the third leading cause of death in the developed world and the leading cause of serious long-term disability. Ischemic stroke represents over 85% of strokes and occurs when a blockage or clot develops in one of the arteries supplying blood to the brain. In 2004 the FDA cleared Concentric Medical's Merci Retriever® for use in patients who are ineligible for IV-tPA or who fail to respond to IV-tPA therapy. This pioneering device creates a departure from the historic method of caring for stroke patients and offers physicians and patients a long-awaited option for stroke intervention.
SOURCE Concentric Medical, Inc.